Acrivastine RC01234
2 Inquiries
87848-99-5
Pharmaceutical Grade
99%
Royalchem
25kg/drum
2029-12-31
Pharmaceutical intermediates
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceAcrivastine (BW825C) is a short acting histamine 1 receptor antagonist for the treatment of allergic rhinitis.Basic Info
-
Product Name:
Acrivastine
Other Name:2-Propenoic acid,3-[6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl]-,(2E)-;2-Propenoic acid,3-[6-[1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-,(E,E)-;2-Propenoic acid,3-[6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-,(2E)-;(2E)-3-[6-[(1E)-1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl]-2-propenoic acid;BW 825C;Acrivastine;BW A825C;BW 0270C;Semprex
CAS No.:87848-99-5
Molecular Formula:C22H24N2O2
InChIKeys:InChIKey=PWACSDKDOHSSQD-IUTFFREVSA-N
Molecular Weight:348.44
Exact Mass:348.44
EC Number:618-080-6
Categories:
Characteristics-
PSA:
53.4
XLogP3:1.6
Appearance:white to beige
Density:1.2±0.1 g/cm3
Melting Point:222 °C (decomp)
Flash Point:289.5±30.1 °C
Refractive Index:1.627
Water Solubility:DMSO: >2mg/mL (warmed)
Storage Conditions:2-8°C
Hazard IdentificationClassification of the substance or mixture
Not classified.
GHS label elements, including precautionary statements
Pictogram(s) No symbol. Signal word No signal word
Hazard statement(s) none
Precautionary statement(s) Prevention none
Response none
Storage none
Disposal none
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Pharmaceutical intermediates
-
Location:
Room 336, Building 7, No. 177 Xingqiao North Road, Xingqiao Street, Linping District, Hangzhou
-
Payment Terms:
TT against copy of documents,D/P,L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
14
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
Less than 5
-
Year of Establishment:
2025
-
-
Inquiry History2 Inquiries
Country Product Purchase Quantity Date Posted 
India
Acrivastine
20 Oct 30, 2023
India
Acrivastine
20 G Oct 28, 2023 Post an enquiry for this product
